Ongoing investigations into the drug are showcasing promising outcomes regarding body composition . Initially created for managing type 2 diabetes , this GLP-1 receptor agonist has indicated https://wholesalepeptides.uk/retatrutide-vs-tirzepatide-the-next-evolution-in-metabolic-enhancement/